TROY DYNAJEC INJECTION - MUSCULAR STIMULANT FOR HORSES AND DOGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

POTASSIUM ASPARTATE; MAGNESIUM ASPARTATE; HEPTAMINOL HYDROCHLORIDE; SODIUM SELENITE; DISODIC ADENOSINE MONOPHOSPHATE; CYANOCOBALAMIN (VITAMIN B12)

Available from:

TROY LABORATORIES PTY LTD

INN (International Name):

sodium selenite(0.5mg/mL)+magnesium aspartate(15mg/mL) + others

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

POTASSIUM ASPARTATE AMINO ACID-ASPARTATE Active 10.0 mg/ml; MAGNESIUM ASPARTATE AMINO ACID-ASPARTATE Active 15.0 mg/ml; HEPTAMINOL HYDROCHLORIDE AMINE/AMIDE Active 5.0 mg/ml; SODIUM SELENITE MINERAL-SELENIUM Active 0.5 mg/ml; DISODIC ADENOSINE MONOPHOSPHATE NUCLEOTIDE Active 2.0 mg/ml; CYANOCOBALAMIN (VITAMIN B12) VITAMIN-B12 Active 250.0 ug/ml

Units in package:

100mL

Class:

VM - Veterinary Medicine

Manufactured by:

TROY LABORATORIES

Therapeutic group:

DOG | HORSE | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT

Therapeutic area:

NUTRITION & METABOLISM

Therapeutic indications:

AZOTURIA | EXERTIONAL RHABDOMYOLYSIS | TYING-UP

Product summary:

Poison schedule: 6; Withholding period: WHP: NIL; Host/pest details: DOG: [AZOTURIA]; HORSE: [AZOTURIA]; Poison schedule: 6; Withholding period: ; Host/pest details: DOG: [AZOTURIA]; HORSE: [AZOTURIA]; An aid in the control of exertional rhabdomyolysis (ER) in horses and dogs (tying up syndrome in horses).

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                12
53
52
53
51.25
31.5
85
31.5
50.25
12.25
105
211
File Name: 63237_45099_100ML_CARTON_MPL_V2
Dimensions: 53 x 52 x 85mm
Scale: A3 = 100% to scale
Date: 6 April 2010
ACTIVE CONSTITUENTS:
Sodium selenite 0.5 mg/mL
Magnesium aspartate 15.0 mg/mL
Potassium aspartate 10.0 mg/mL
Cyanocobalamin 250 µg/mL
Heptaminol hydrochloride 5.0 mg/mL
Disodic adenosine monophosphate 2.0 mg/mL
ACTIVE CONSTITUENTS:
Sodium selenite 0.5 mg/mL
Magnesium aspartate 15.0 mg/mL
Potassium aspartate 10.0 mg/mL
Cyanocobalamin 250 µg/mL
Heptaminol hydrochloride 5.0 mg/mL
Disodic adenosine monophosphate 2.0 mg/mL
100mL
100mL
100mL
Plastic Vial
Plastic Vial
CD1213
9313754221302
barcode
Muscular Stimulant for horses and dogs
Muscular Stimulant for horses and dogs
Muscular Stimulant for horses and dogs
_An aid in the control of Exertional _
_Rhabdomyolysis (ER) in horses and dogs_
_(tying up syndrome in horses)_
_An aid in the control of Exertional _
_Rhabdomyolysis (ER) in horses and dogs_
_(tying up syndrome in horses)_
POISON
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
POISON
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
DIRECTIONS FOR USE
Use the contents of this vial within 90 days of initial
broaching. Discard the unused contents.
DOSAGE AND ADMINISTRATION
Administer via intramuscular or subcutaneous injection
Treatment
1 injection once every 3
days for 9 to 12 days
Prevention
1 injection once a week for
2 to 3 weeks
Horses - Adult
20mL
Horses - Foals
10 mL
Dogs
2 to 5 mL according to
size by subcutaneous or
intramuscular route
If used in performance animals, the regulations of the
relevant authorities regarding medication should be
observed.
MEAT WITHHOLDING PERIOD NIL
FIRST AID
If poisoning occurs, contact a doctor or Poisons
Information Centre. Phone Australia 131126.
If skin contact occurs, remove contaminated
clothing and wash skin thoroughly.
TROY LABORATORIES PTY. LIMITED
98 LONG ST SMITHFIELD, NSW 2164
W: www.troylab.com.au
E: info@troylab.com.au
DISPOSAL
Dispose of empty container by wrapping with paper
and pu
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                MATERIAL SAFETY DATA SHEET
PRODUCT NAME: TROY DYNAJEC INJECTION - MUSCULAR STIMULANT FOR HORSES
AND DOGS
PAGE: 1 OF 5
THIS REVISION ISSUED: SEPTEMBER, 2011
MATERIAL SAFETY DATA SHEET
Issued by: Troy Laboratories Pty Ltd
Phone: 02 9677 9000
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
(02) 9677 9000
31-35 GLENDENNING ROAD
FAX:
(02) 9677 9300
GLENDENNING NSW 2761
CHEMICAL NATURE:
Blend of ingredients in water solution; presented as an injectable
solution.
TRADE NAME:
TROY DYNAJEC INJECTION - MUSCULAR STIMULANT FOR HORSES AND DOGS
APVMA CODE:
63237
PRODUCT USE:
An aid in the control of muscular dystrophy in horses and dogs
(tying-up syndrome in
horses) for use as described on the product label.
CREATION DATE:
SEPTEMBER, 2011
THIS VERSION ISSUED:
SEPTEMBER, 2011
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R33. Danger of cumulative effects.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSMP CLASSIFICATION:
S6
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear red to dark red liquid.
ODOUR:
Slight alcohol-like odour.
MAJOR HEALTH HAZARDS:
danger of cumulative effects.
POTENTIAL HEALTH EFFECTS
On injection, heptaminol has an adrenalin-like action in horses. 20g
heptaminol is equivalent to the action produced
by 0.5mg adrenalin.
INHALATION:
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that
this product is not harmful. In addition product is unlikely to cause
any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects 
                                
                                Read the complete document